IRadimed Corp (IRMD) stock
IRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3057% above fair value
$83.45−1.39 (-1.64%)
Close on Nov 17, 2026Market cap $1.07BP/E 44.6Yield –
IRadimed price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
IRadimed's price to sales ratio was 12.8× on Nov 11, 2026, against 14.7× a year earlier. Over the last 5 years it ranged from 7.1× to 15.8×, with a median of 9.8×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 12.8× | −2.5 |
| 2025 | Dec 31, 2025 | 15.4× | +5.6 |
| 2024 | Dec 31, 2024 | 9.8× | +0.3 |
| 2023 | Dec 29, 2023 | 9.5× | +2.4 |
| 2022 | Dec 30, 2022 | 7.1× | −7.8 |
| 2021 | Dec 31, 2021 | 14.8× | +6.6 |
| 2020 | Dec 31, 2020 | 8.2× | +0.8 |
| 2019 | Dec 31, 2019 | 7.4× | −1.9 |
| 2018 | Dec 31, 2018 | 9.3× | +2.1 |
| 2017 | Dec 29, 2017 | 7.1× | +3.8 |
| 2016 | Dec 30, 2016 | 3.4× | −8.4 |
| 2015 | Dec 31, 2015 | 11.8× | +2.9 |
| 2014 | Dec 31, 2014 | 8.9× | – |
See a number that looks wrong?